Image (Nitrofurantoin 01)
Nitrofurantoin (monohydrate/macrocrystals) Capsule
Product Images NDC 67296-2180
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nitrofurantoin (monohydrate/macrocrystals) (NDC 67296-2180). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Nitrofurantoin 02)
Image-03 (Nitrofurantoin 03)
This text is a description of Nitrofurantoin Capsules, USP used for urinary tract antibacterial treatment. Each capsule contains 100 mg nitrofurantoin in the form of 25 mg nitrofurantoin macrocrystals and 75 mg of nitrofurantoin monohydrate. It is recommended for adults to take one 100-mg capsule every 12 hours with food. The medication should be stored in a controlled room temperature. The bulk container is not intended for dispensing and should be stored in a tight container. The manufacturer is Inventia Healthcare Limited in India, and it is marketed by Jubilant Cadista Pharmaceuticals Inc. in the USA.*
Image-04 (Nitrofurantoin 04)
This text contains information about a medication in capsule form containing 100 mg of nitrofurantoin for the treatment of urinary tract infections. It provides the usual dosage for adults and prescribing information. The capsules are manufactured by Inventia Healthcare Limited in India and marketed by Jubilant Cadista Pharmaceuticals Inc. in the USA. The medication is intended for dispensing and should be stored in a tight container. The text also mentions the manufacturer's address and a code for the product.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
